You Position: Home > Journal Detail
All Issues
2024:
2023:
2022:
2021:
2020:
2019:
2018:
2017:
2016:
2015:
2014:
2013:
2012:
2011:
Anti-Tumor Pharmacy
- ISSN:
- 2095-1264
- CN:
- 43-1507/R
- Founded in:
- 2011
- Sponsor:
- 湖南省卫生厅
- Email:
- zgzlyx2011@126.com
《肿瘤药学》杂志是经国家新闻出版总署批准，由湖南省肿瘤医院主办的涉及肿瘤学、药学领域的专业学术期刊。《肿瘤药学》于2011年2月创刊，双月刊，大16开，内芯80页，4色印刷，面向国内外公开发行。国际刊号：ISSN 2095-1264，国内统一刊号：CN 43-1507/R。目前已被美国《化学文摘》、《乌利希期刊指南》、中国学术期刊网络出版总库、中文科技期刊数据库、万方-数字化期刊群、中国核心期刊（遴选）数据库收录。正在接受评估的国外数据库有：美国《国际药学文摘》、波兰《哥白尼索引》、英国《全球健康》。 《肿瘤药学》杂志以推动肿瘤药学的学科发展，加强肿瘤药物治疗经验的交流，促进肿瘤药物的研发，提高临床合理用药水平为宗旨，以面向医师、药师、护师及药物研究、生产、教学、营销等领域的工作者，打造国内抗肿瘤药物基础与临床研究、合理用药和新药研发的学术性、实用性、创新性的专业期刊，向“国内一流、国际接轨”核心期刊迈进为目标，力争成为承载国内外同行最新学术研究成果的交流平台。
- 1: Review of the prescriptions of novel anti-tumor drugs in a hospital and analysis of drug application (朱智云 王德平 张兴飞)
- 2: Observing the effect of resveratrol on colitis-associated colorectal cancer based on TLR4/MyD88/NF-κB signaling pathway (蔡振华 游晓娟 严云龙 林秋江)
- 3: A case of interstitial lung disease caused by osimertinib mesylate and literature review (李春梅 张英 赵海明 赵文瑞 代亚军)
- 4: Comprehensive pharmaceutical care for a patient with metastatic colorectal cancer treated with third-line therapy (李秦川 田姗姗)
- 5: A case report of recurrent ovarian cancer with pericardial metastasis and literature review (杜顺喜 杨宏英)
- 6: Research progress on the role of growth differentiation factor 15 in the pathogenesis of multiple myeloma (范宏杰 涂生柯 宋奎)
- 7: Risk prediction models for chemotherapy-induced myelosuppression in cancer patients (黄新娟 李旭英 谌永毅 黄钢 李金花 樊溶榕 陈洪赟)
- 8: 会议速递 (董珊珊 房超)
- 9: Medication knowledge popularization intervention on thyroid cancer patients after surgery and its effect evaluation (李娟 任威 戴助)
- 10: Bibliometrics-based analysis of the current state of research on blinatumomab for acute lymphoblastic leukemia (李昭文 何莉梅 燕梦瑶)
- 11: Mechanism of CMIP promoting drug resistance to doxorubicin in human colon cancer (周丽 周大新 谢方利 李祥兵)
- 12: Non-target plasma metabolomics of Weifufang in SGC-7901 tumor-bearing nude mice (唐麒 孙蕊 卞希岚 焦蕉 李淑敏 李东芳)
- 13: Research progress on the role and mechanism of berberine in regulating the microenvironment of ovarian cancer (王甜慧 刘芳媛 马宇婷 韩凤娟)
- 14: Analysis of immune-related adverse events induced by PD-1/PD-L1 inhibitors based on FAERS (柳鹏程 徐晓丽 敬赟鑫 周明 刘源)
- 15: Investigation on the symptom clusters and symptom distress status of adult patients with brain glioma and analysis of the influencing factors (李游 周元 袁慧 李菊花 童孜容 陈华玉 王瑶 郭安娜 钱美玲)
- 16: Research on signal mining of adverse events of sorafenib and regorafenib based on OpenVigil (李时 石亚飞 贾贝 薄明明 马兰凤 常爱冰 武文昊 孙伟銮 李国辉 戴媛媛)
- 17: Expression of miR-145 in Helicobacter pylori-related gastric cancer and its clinical significance (王军生 李祥佩 王屹燃 许琳 陈光侠)
- 18: HER2-low expression breast cancer:past,present and future (田璨 欧阳取长)
- 19: The bleeding risk of patients with metastatic renal cell carcinoma treated with VEGFR inhibitors:a meta-analysis (刘云霞 狄国杰 袁珊 程文聪 张文)
- 20: Immune-related myocarditis due to combination of sintilimab,oxaliplatin and tegafur gimercil and oteracil porassium capsule for gastric cardia adenocarcinoma and literature review (张凇 佟菲 宁华 张艳华 李然)